Reuters logo
BRIEF- Zhejiang Hisoar Pharmaceutical sees H1 2017 net profit down 1.3-21 pct
April 21, 2017 / 8:34 AM / 7 months ago

BRIEF- Zhejiang Hisoar Pharmaceutical sees H1 2017 net profit down 1.3-21 pct

April 21 (Reuters) - Zhejiang Hisoar Pharmaceutical Co Ltd :

* Sees net profit for H1 2017 to decrease by 1.3 percent to 21 percent, or to be 240 million yuan to 300 million yuan, compared to net profit of the same period in 2016 (304.0 million yuan)

* Comments that increased costs of dye product is the main reason for the forecast

Source text in Chinese: goo.gl/Y6kDcy

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below